Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Carcinoma, Non-Small-Cell Lung 26Lung Neoplasms 23Neoplasms 7Small Cell Lung Carcinoma 5Neoplasm Metastasis 4Mesothelioma 4Breast Neoplasms 4Vomiting 3Nausea 3Triple Negative Breast Neoplasms 2Parkinson Disease 4, Autosomal Dominant Lewy Body 2Pancreatic Neoplasms 2Ovarian Neoplasms 2Kidney Neoplasms 2Head and Neck Neoplasms 2Brain Neoplasms 2Stomach Neoplasms 1Radiation Pneumonitis 1Postoperative Complications 1Pain, Postoperative 1Nasopharyngeal Neoplasms 1Multiple Myeloma 1Mesothelioma, Malignant 1Melanoma 1Malnutrition 1Lymphoma 1Lung Diseases, Interstitial 1Liver Neoplasms 1Esophageal Neoplasms 1Endometrial Neoplasms 1

Interventions

perflutren 1Thoracoscopy 1Surveys and Questionnaires 1Sulfur Hexafluoride 1Radiotherapy 1Prednisone 1Observation 1Lidocaine 1Health Records, Personal 1Drug Delivery Systems 1Dexamethasone 1Conscious Sedation 1Clinical Protocols 1Bronchoscopy 1Blood Pressure 1Adrenal Cortex Hormones 1Acetylcysteine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lung Diseases, Interstitial × Dexamethasone × Thoracic × Clear all
NCT05986318 2026-03-09

RESPIRE-ILD

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Phase 2 Recruiting
98 enrolled
Thoracic

Lung Neoplasms, Lung Diseases, Interstitial, Radiation Pneumonitis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡